Company intelligence / Profile preview

Clarix Imaging

Chicago, Illinois, United States

Ownership: Private
Employees: ~19
Development stage: Other

Overview

Commercial-stage company with FDA-cleared VSI-360 system demonstrating 91-94% sensitivity and 81-85% specificity in correlating intraoperative imaging to post-surgical pathology for breast cancer lumpectomy margins[1][6][7].

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Partnerships

Mayo Clinickineo finance

Beyond the preview

Go deeper on Clarix Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarix Imaging.

Explore the full profile